MolPort-002-045-698

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

35 Suppliers, 13 USDMF, 8 CEP/COS, 3 JDMF, 1 EU WC, 5 KDMF, 10 NDC API, 22 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports

INTERMEDIATES

1 Suppliers

1 Suppliers

DOSSIERs // Finished Dosage Forms

131 Dossiers, 35 FDA Orange Book, 40 Europe, 10 Canada, 28 Australia, 1 South Africa, 17 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 0.25MCG, CAPSULE;ORAL - 0.5MCG, INJECTABLE;INJECTION - 0.001MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 0.002MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 19 Roquette, 16 SPI Pharma, 5 Actylis, 5 Gangwal Healthcare, 4 Seppic, 4 ACG Worldwide, 4 BASF, 4 Nanjing Well Pharmaceutical, 4 Kerry, 3 Gangwal Chemicals, 3 Lonza Capsugel, 3 Ingredion Pharma Solutions, 2 DKSH, 2 Rochem International Inc, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Microlex e.U, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Qualicaps, 1 Sigachi Industries, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Zhejiang Huakang Pharmaceutical, 1 Finar, 1 Pfanstiehl

EXCIPIENTS BY APPLICATIONS

33 Fillers, Diluents & Binders, 16 Taste Masking, 15 Direct Compression, 14 Parenteral, 14 Chewable & Orodispersible Aids, 11 Film Formers & Plasticizers, 8 Empty Capsules, 8 Coating Systems & Additives, 7 Co-Processed Excipients, 6 Solubilizers, 6 Disintegrants & Superdisintegrants, 5 Topical, 4 Granulation, 3 Controlled & Modified Release, 3 Thickeners and Stabilizers, 1 API Stability Enhancers, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

23 US Medicaid Prescriptions, 46 Finished Drug Prices

MARKET PLACE

8 APIs, 12 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

2 EDQM Standards, 2 USP Standards, 2 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 5 News

Annual Sales of MolPort-002-045-698 reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

MolPort-002-045-698

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

35 Suppliers

13 USDMF

8 CEP/COS

3 JDMF

1 EU WC

5 KDMF

10 NDC API

22 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

1 Suppliers

DOSSIERs // Finished Dosage Forms

131 Dossiers

35 FDA Orange Book

40 Europe

10 Canada

28 Australia

1 South Africa

17 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 0.25MCG

CAPSULE;ORAL - 0.5MCG

INJECTABLE;INJECTION - 0.001MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 0.002MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

19 Roquette

16 SPI Pharma

5 Actylis

5 Gangwal Healthcare

4 Seppic

4 ACG Worldwide

4 BASF

4 Nanjing Well Pharmaceutical

4 Kerry

3 Gangwal Chemicals

3 Lonza Capsugel

3 Ingredion Pharma Solutions

2 DKSH

2 Rochem International Inc

2 Shijiazhuang Huaxu Pharmaceutical

2 Microlex e.U

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Qualicaps

1 Sigachi Industries

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Zhejiang Huakang Pharmaceutical

1 Finar

1 Pfanstiehl

EXCIPIENTS BY APPLICATIONS

33 Fillers, Diluents & Binders

16 Taste Masking

15 Direct Compression

14 Parenteral

14 Chewable & Orodispersible Aids

11 Film Formers & Plasticizers

8 Empty Capsules

8 Coating Systems & Additives

7 Co-Processed Excipients

6 Solubilizers

6 Disintegrants & Superdisintegrants

5 Topical

4 Granulation

3 Controlled & Modified Release

3 Thickeners and Stabilizers

1 API Stability Enhancers

1 Soft Gelatin

1 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

23 US Medicaid Prescriptions

46 Finished Drug Prices

MARKET PLACE

INJECTABLE;INJECTION - 0.001MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 0.002MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons